This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally.

In this virtual webinar, leading expert Dr Sue Pedersen explores personalised strategies for obesity care and the integration of guideline-concordant treatment approaches. Dr Pedersen will review the evolution of escalation and de-escalation frameworks in clinical practice, outline evidence-based timing for advancing therapy when lifestyle interventions are insufficient, and demonstrate how to layer pharmacological options within structured follow-up workflows to optimise patient outcomes and long-term quality of life.

Endocrinologist Dr Patrice Forner will provide an Australian perspective, focusing on the application of national obesity guidelines within primary care and offering practical, patient-centred communication strategies to support bias-aware, collaborative conversations and the delivery of individualised obesity care in the Australian context.

Accreditation: 1 AMA PRA Category 1 Credits™

Session Highlights

• Guidelines in practice: Initiate and sustain long-term, evidence-based obesity management plans integrating lifestyle, pharmacotherapy, and referral strategies.
• Structured follow-up: Design dedicated weight-management visits with predefined monitoring metrics and escalation triggers.
• Integrated care: Embed obesity treatment within chronic disease management pathways for sustained outcomes.
• Patient-centred approach: Communicate with empathy, address bias and stigma, and co-create individualised management plans.

Who Should Watch

• Primary Care Physicians
• Primary Care Team
• Nurse Practitioners
• Physician Assistants

Presented by

Sue D. Pedersen, MD, FRCPC – Specialist in Endocrinology and Metabolism; American Board of Obesity Medicine; Clinical Lecturer, University of Calgary. Dr Pedersen’s clinical research and leadership in national and global obesity pharmacotherapy trials, as well as her authorship of the Canadian Obesity Clinical Practice Guidelines, have shaped evidence-based strategies for diabetes and obesity management.

Dr Patrice Forner, MBBS, BNutDiet, Endocrinologist and Clinical Lecturer, Sydney, NSW.

Continuing Education Information

Commercial support: This activity received monetary support through an independent education grant from Lilly.

This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.

Disclosures

Dr Sue Pedersen has disclosed financial relationships within the past 24 months with the following ineligible companies: AstraZeneca, Bausch, Eli Lilly, Novo Nordisk, Janssen, Boehringer, Sanofi, Merck, Abbott, Dexcom, HLS, GSK, Bayer, Pfizer, AbbVie, Roche, Amgen, Prometic, and Regeneron. These relationships include honoraria, participation on advisory boards or speakers’ bureaus, and involvement in research and clinical trials.

These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. Dr Pedersen intends to discuss non-FDA uses of drug products and/or devices only in relation to products for which she has no financial relationships. She will disclose to the audience when this discussion takes place.

Dr Patrice Forner has disclosed a financial relationship within the past 24 months with the following ineligible company: Roche (honoraria). This disclosure is made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. Dr Forner does not intend to discuss non-FDA uses of drug products and/or devices.

AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.

Unapproved and/or off-label use disclosure

AffinityCE/MedAll requires CE faculty to disclose to the participants:

• When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
• Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.

Participation Costs

There is no cost to participate in this program.

This continuing education activity is active starting November 13th 2025 and will expire on November 13th 2025. Estimated time to complete this activity: 60 minutes.